Licourt OD, Cala HO, Travieso TA, Orraca CM

Language: Spanish
References: 16
Page: 141-150
PDF size: 175.66 Kb.

ABSTRACT

Current knowledge suggests that epilepsy is clinically and genetically heterogeneous. Inherited factors seem to suggest any genetic susceptibility, but with any exceptions; on their own they are neither capable of provoking any clinical manifestations nor follow classic Mendelian inheritance patterns. The degree of genetic penetrance may depend greatly on other genes which, together with environmental factors, may contribute with the development and worsening of epilepsy. Genetic heterogeneity of epilepsy was described by reporting three families; other individuals have been studied in these families starting from index case, with consanguinity, suffering from several types of epilepsies, disabilities and diseases of multifactorial origin. This is a new topic applied to the field of medical genetics, projected towards the diseases of multifactorial origin.

REFERENCES

1. Rosado García FM, Núñez Fernández FA, Ruiz Espinosa A, Rojas Rivero L, Andrade Machado R, Kanaobana K, Polman K. Parasitosis intestinales en pacientes con epilepsia de origen desconocido. Rev Cubana Med Trop. abr-jun. 2013; 65(2).

2. Conde Pérez YA, Díaz González D, Conde Pérez M, Navia Reyes I, Conde Fernández B. Epidemiología clínica de la epilepsia en la población adulta del municipio Sancti Spíritus. Gac Méd Espirit. mayo-ago. 2013; 15(2).

3. Iglesias More S, Fabelo Roche JR, Rojas Velásquez Y, González Pal R, Ramírez Muñoz A. Calidad de vida en niños y adolescentes con epilepsia. Rev Cubana Enfermer. abr.-jun. 2012; 28 (2).

4. Gustavo A. Charria-Ortiz. Genética de las epilepsias. Actualizaciones en neurología infantil medicina. 2007; 67(1).

5. Pal D.K, Greenberg D.A. Evaluating Genetic Heterogeneity in Complex Disorders. Human Heredity. 2002; 53(4).

6. Lantigua Cruz A. Introducción a la Genética Médica. La Habana: Editorial Ciencias Médicas; 160-161.

7. Maradei-Anaya SJ, Espinosa E, Izquierdo A, Velasco-Parra HM. Detección de rearreglos subteloméricos por MLPA en pacientes pediátricos con epilepsia refractaria en Colombia: papel del gen CHL1 en la farmacorresistencia. Rev Neurol. 2013; 57(10).

8. Artigas-Pallarés J, Guitart M, Gabau-Vila E. Bases genéticas de los trastornos del neurodesarrollo. Rev Neurol 2013 56 (Supl 1).

9. Weizmann Institute of Medicine. Crown Human Genome Center, Department of Molecular Genetics. The Human Gene Compendium. GeneCards: CHL1. 2013.

10. Meisler MH, O'Brien JE. Gene Interactions and Modifiers in Epilepsy. In: Jasper's Basic Mechanisms of the Epilepsies. 4th edition; USA: Oxford University Press; 2012.

11. Jeffrey L Noebels, Massimo Avoli, Michael A Rogawski, Richard W Olsen, Delgado-Escueta AV. Jasper's Basic Mechanisms of the Epilepsies. 2012; 4th edition.

12. Ruth Ottman, Neil Risch. Genetic Epidemiology and Gene Discovery in Epilepsy. In: Jasper's Basic Mechanisms of the Epilepsies. 2012; 4th edition.

13. Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010; 86(5).

14. Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C, et al. A copy number variation morbidity map of developmental delay. Nat Genet[serie en Internet]. 2011; 43.

15. Coe BP, Girirajan S, Eichler EE. The genetic variability and commonality of neurodevelopmental disease. Am J Med Genet Part C Semin Med. 2012; 160C (2).

16. Kaminsky EB, Kaul V, Paschall J, Church DM, Bunke B, Kunig D, et al. An evidence based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities. Genet Med. 2011.; 13(9).